To improve the quality of cancer care with early and accurate diagnosis
The Agkura ® Personal Score is a simple revolutionary blood test that can accurately detect a protein called tMUC1 that is associated with 95% of breast cancers. This protein is present in healthy individuals too and is a result of the immune system killing cancer cells soon after they are formed. The levels of tMUC1 are steady in healthy individuals and increase over time when cancer grows by escaping immune surveillance. Thus with serial monitoring of tMUC1 levels, breast cancer can be detected in its earliest growth phase.
The Agkura ® Personal Score was developed by OncoTAb, Inc., a US based biotechnology company that was founded by a leading cancer scientist Dr. Pinku Mukherjee, a Mayo Clinic alumna. In a study in the USA, the Agkura ® Personal Score demonstrated the ability to preferentially detect the growth of aggressive breast cancers up to 2 years before the detection of a lump or detection by screening mammography.
The critical values for this test have been re-established for the Indian population. A study in Indian women has also demonstrated that serial monitoring with Agkura ® Personal Score will aid in the earlier detection of breast cancer. This test is useful for women at high risk (testing every 6 months) who need to know when to intervene, as well as those at average risk (testing annually) seeking peace of mind with a non-invasive test.
Fill up the form and send it to us. Our representative will contact you .
CALL US on: 9074558948, 9074558949
To improve the quality of cancer care with early and accurate diagnosis
